Osteoporosis, a silent disease

被引：0

作者：

David, Claire ^{[1
]}

Boinet, Tomas ^{[2
]}

机构：

[1] Ctr Hosp St Calais, Serv Pharm, 2 Rue Perrine, F-72120 St Calais, France

[2] Ctr Municipal Sante, Rue Petit Train, F-72160 Connerre, France

来源：

ACTUALITES PHARMACEUTIQUES | 2019年 / 58卷 / 585期

关键词：

compliance; densitometry; fracture; menopause; osteoporosis; recommendation;

D O I：

10.1016/j.actpha.2019.02.002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Osteoporosis, a silent disease. Osteoporosis, the most common metabolic disease of the bone tissue, is responsible for bone fragility with an increased risk of fractures. A significant cause of morbidity in the elderly and post-menopausal women, its treatment is statistically inadequate despite there being up-to-date guidelines. The pharmacist must be equipped with prevention and risk assessment tools, and ensure compliance with the duration of effective codified therapies. (C) 2019 Elsevier Masson SAS. All rights reserved

引用

页码：12 / 16

页数：5

共 9 条

[1] Agence nationale de securite sanitaire de l'alimentation de l'environnement et du travail (Anses), LE CALC
[2] Association francaise de lutte antirhumatismale (Afl ar), LOST
[3] Briot K, 2018, Rev Rhum, V85, P428
[4] College francais des enseignants en rhumatologie (Cofer), OST CAMP RHUM U NUM
[5] Delprat J., 2015, THESIS
[6] Groupe de recherche et d'information sur les osteoporoses (Grio), CALC APP CALC QUOT
[7] Haute Autorite de sante (HAS), 2014, BON US MED MED OST
[8] Isselbacher KJ, 1995, MED INTERNE
[9] Vital Durand D, 2017, DOROSZ GUIDE PRATIQU

← 1 →